SOP Reference Number: | SOP Document: |
C-2001: | Informed Consent |
C-2002: | Processing and Reporting of SAEs, SARs and SUSARs |
C-2003: | Principal Investigator Responsibilities |
C-2005: | Training for Staff Engaged in Research Hosted by Leicester’s Hospitals |
C-2006: | Expression of Interest, Feasibility and Site Selection Process |
C-2006a: | Dealing with Expressions of Interest, Feasibility, Capability and Site Selection |
C-2009: | Management of Essential Documents & Study Filing for Research Hosted by Leicester’s Hospitals |
C-2011: | Authorisation of Amendments or Additions to Documents for Studies Already Authorised |
C-2012: | Management of Contracts for Research Hosted by Leicester’s Hospitals |
C-2013: | Procedure in the Event of Non-Compliance |
C-2014: | Management & Production of Corrective & Preventative Action Plan (CAPA) |
C-2015: | Identifying & Reporting Deviations & Serious Breaches of GCP |
C-2016: | Management of Suspected Fraud & Misconduct |
C-2017: | Archiving of Essential Documents |
C-2018: | End of Study Reporting Requirements |
C-2019: | Obtaining Finance Approval |
C-2022: | UHL Pandemic Plan for Research |
J-5004: | UHL Confirmation of C&C for Hosted Research |
C-2025: | Priority & Expedited Capacity & Capability Assessment |
C-2027: | UHL Re-Opening Studies During Pandemic |
C-2028: | UHL Remote Monitoring |
C-2030: | UHL Healthy Volunteers in Hosted Research |
J-5005: | UHL Implementing PRES (Participants in Research Experience Survey) |
J-5006: | UHL- Randomisation & Blinding for Research Studies (Both Sponsored and Hosted) |
C-2001 SOP for Informed Consent: | Appendix 1 – Delegation of Authority and Signature Log |
C-2002 SOP for Processing and Reporting of SAEs, SARs and SUSARs: | Appendix 1 – Pregnancy Reporting Form Appendix 2 – CTIMP Line Listing Appendix 3 – Non-CTIMP Line Listing Appendix 4 – SAE Line Listing Reminder Email Appendix 5 – SAE Line Listing Second Reminder Email Appendix 6 – SAE Line Listing Final Reminder Email Appendix 7 – SAE Line Listing Request for Further Information Appendix 8 – Acknowledgement of SAE Line Listing Email Appendix 9 – SAE Line Listing Workflow |
C-2003 Principle Investigator Responsibilities: | Appendix 1 - Roles and Responsibilities of PI Agreement Appendix 2 - Blank Host DOA and Signature Log |
C-2009 SOP for Management of Essential Documents and Study Filing for Research Hosted by Leicester’s Hospitals: | Appendix 1 – Investigator Site File Index for Clinical Trials of Investigational Medicinal Products Appendix 1a - ISF Non UKCA CE Marked Medical Device Studies Appendix 2 – Investigator Site File Index for Studies NOT Involving Investigational Medicinal Products Appendix 2a - ISF UKCA CE Marked Medical Device Studies Appendix 3 - ISF Version Control Document |
C-2014 Management and Production of Corrective and Preventative Action Plan (CAPA): | Appendix 1 – CAPA Template |
C-2015 SOP for Identifying and Reporting Deviations and Serious Breaches of GCP: | Appendix 1 – Site File Note Template |
C-2016 SOP for the Management of Suspected Fraud and Misconduct: | Appendix 1 – Suspected Fraud or Misconduct Initial Investigation Template Appendix 2 – Suspected Fraud or Misconduct Interview Template Appendix 3 – Evidence Listing Template |
C-2027 SOP for Re-Opening Studies During Pandemic: | Appendix 1 – Process for Consideration During COVID-19 Pandemic Appendix 2 – Re-Opening Studies During Pandemic Flowchart |
C-2028 UHL Remote Monitoring: | Appendix 1 - Remote Monitoring Risk Assessment |
J-5005 UHL Implementing PRES (Trust Reference Pending): | Appendix 1 - Study Reporting Template Appendix 2 - Useful Links |
J-5009 | Management of contracts |
J-5010 | Set up and Management of Phase I Trials |